BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sperti C, Moletta L, Merigliano S. Multimodality treatment of recurrent pancreatic cancer: Mith or reality? World J Gastrointest Oncol 2015; 7(12): 375-382 [PMID: 26689800 DOI: 10.4251/wjgo.v7.i12.375]
URL: https://www.wjgnet.com/1948-5190/full/v7/i12/375.htm
Number Citing Articles
1
Nitin Sudhakar Shetty, Ujjwal Agarwal, Amit Choudhari, Anurag Gupta, Nandakumar PG, Manish Bhandare, Kunal Gala, Daksh Chandra, Anant Ramaswamy, Vikas Ostwal, Shailesh V. Shrikhande, Suyash S. Kulkarni. Imaging Recommendations for Diagnosis, Staging, and Management of Pancreatic CancerIndian Journal of Medical and Paediatric Oncology 2023; 44(01): 077 doi: 10.1055/s-0042-1759521
2
Marcus Holmberg, Stefan Linder, Maximilian Kordes, Maria Liljefors, Poya Ghorbani, J-Matthias Löhr, Ernesto Sparrelid. Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia – A comparison with pancreatic ductal adenocarcinomaPancreatology 2022; 22(5): 598 doi: 10.1016/j.pan.2022.04.007
3
Shigeru Fujisaki, Motoi Takashina, Ryouichi Tomita, Kenichi Sakurai, Tadatoshi Takayama. Long-term survival following hepatectomy, radiation, and chemotherapy for recurrent pancreatic carcinoma: a case reportWorld Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1232-2
4
Sebastian Zschaeck, Bibiana Blümke, Peter Wust, David Kaul, Marcus Bahra, Hanno Riess, Fritz Klein, Marianne Sinn, Uwe Pelzer, Volker Budach, Pirus Ghadjar, Aamir Ahmad. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patientsPLOS ONE 2017; 12(10): e0186341 doi: 10.1371/journal.pone.0186341
5
Lois A. Daamen, V. P. Groot, I. Q. Molenaar. Textbook of Pancreatic Cancer2021; : 1121 doi: 10.1007/978-3-030-53786-9_72
6
Lucia Moletta, Simone Serafini, Michele Valmasoni, Elisa Sefora Pierobon, Alberto Ponzoni, Cosimo Sperti. Surgery for Recurrent Pancreatic Cancer: Is It Effective?Cancers 2019; 11(7): 991 doi: 10.3390/cancers11070991
7
L.A. Daamen, V.P. Groot, M.P.W. Intven, M.G. Besselink, O.R. Busch, B. Groot Koerkamp, N. Haj Mohammad, J.J. Hermans, H.W.M. van Laarhoven, J.J. Nuyttens, J.W. Wilmink, H.C. van Santvoort, I.Q. Molenaar, M.W.J. Stommel. Postoperative surveillance of pancreatic cancer patientsEuropean Journal of Surgical Oncology 2019; 45(10): 1770 doi: 10.1016/j.ejso.2019.05.031
8
Shui-lian Tan, Xiao-ling Yu, Ping Liang, Fangyi Liu, Zhigang Cheng, Zhi-Yu Han, Jie Yu. Preventing intrahepatic infection after ablation of liver tumours in biliary-enteric anastomosis patientsInternational Journal of Hyperthermia 2017; 33(6): 664 doi: 10.1080/02656736.2017.1292002
9
Ting Pan, Yiwen Zhang, Nan Zhou, Xin He, Cancan Chen, Liting Liang, Xiaobing Duan, Yingtong Lin, Kang Wu, Hui Zhang. A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growthOncotarget 2016; 7(28): 44299 doi: 10.18632/oncotarget.9996
10
M Tanaka, A L Mihaljevic, P Probst, M Heckler, U Klaiber, U Heger, M W Büchler, T Hackert. Meta-analysis of recurrence pattern after resection for pancreatic cancerBritish Journal of Surgery 2019; 106(12): 1590 doi: 10.1002/bjs.11295
11
Lois A. Daamen, Vincent P. Groot, Marc G. Besselink, Koop Bosscha, Olivier R. Busch, Geert A. Cirkel, Ronald M. van Dam, Sebastiaan Festen, Bas Groot Koerkamp, Nadia Haj Mohammad, Erwin van der Harst, Ignace H. J. T. de Hingh, Martijn P. W. Intven, Geert Kazemier, Maartje Los, Gert J. Meijer, Vincent E. de Meijer, Vincent B. Nieuwenhuijs, Bobby K. Pranger, Mihaela G. Raicu, Jennifer M. J. Schreinemakers, Martijn W. J. Stommel, Robert C. Verdonk, Helena M. Verkooijen, Izaak Quintus Molenaar, Hjalmar C. van Santvoort. Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the NetherlandsAnnals of Surgery 2022; 275(4): 769 doi: 10.1097/SLA.0000000000004093
12
Dingyuan Hu, Daniel Ansari, Qimin Zhou, Agata Sasor, Katarzyna Said Hilmersson, Monika Bauden, Yi Jiang, Roland Andersson. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinomaBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-5013-2
13
Aren Ebrahimi, Jason Cham, Leah Puglisi, Melanie De Shadarevian, David J. Hermel, Samantha R. Spierling Bagsic, Darren Sigal. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?Cancer Medicine 2023; 12(9): 10243 doi: 10.1002/cam4.5751
14
Johannes Klose, Ulrich Ronellenfitsch, Jörg Kleeff. Management problems in patients with pancreatic cancer from a surgeon's perspectiveSeminars in Oncology 2021; 48(1): 76 doi: 10.1053/j.seminoncol.2021.02.008